89bio to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
SAN FRANCISCO, Sept. 05, 2023 -- 89bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and...